Close Menu

NEW YORK (360Dx) – Mologic today announced its rapid point-of-care test for bacterial vaginosis has received CE marking.

The firm also is commercially launching the test called BVPro and has inked a three-year distribution deal with Sysmex subsidiary Hitado to distribute the test throughout Germany. Mologic did not disclose the terms of the agreement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.